Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 521 entries
View as:

A Study to Assess Pharmacokinetic, Pharmacodynamic, Safety and Tolerability of ASKP1240 in de Novo Kidney Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT01279538 Org: User:
Start: 11/17/10 End: 01/23/12 Due: 01/23/13

Phase II Study of Taxotere in Combination With Exisulind in Non-Small Cell Lung Cancer (NSCLC) Patients

Phase: N/A Priority: Normal
NCT ID: NCT00072618 Org: User:
Start: 10/31/01 End: 08/31/03 Due: 08/31/04

Safety/Efficacy of Induction Agents With Tacrolimus, MMF, and Rapid Steroid Withdrawal in Renal Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT00113269 Org: User:
Start: 05/31/05 End: 03/31/09 Due: 03/31/10

Pharmacokinetics of Oral Mirabegron With Different Release Rates Versus Intravenous (IV) Mirabegron

Phase: N/A Priority: Normal
NCT ID: NCT00940121 Org: User:
Start: 04/30/09 End: 07/13/09 Due: 07/13/10

Long-term Safety of Protopic in Atopic Eczema

Phase: N/A Priority: Normal
NCT ID: NCT00560378 Org: User:
Start: 06/30/98 End: 06/30/05 Due: 06/30/06

A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01071850 Org: User:
Start: 03/03/10 End: 04/11/11 Due: 04/11/12

A Study of Intermittent Oral Dosing of ASP1517 in Peritoneal Dialysis Chronic Kidney Disease Patients With Anemia

Phase: N/A Priority: Normal
NCT ID: NCT02780726 Org: User:
Start: 06/22/16 End: 08/02/17 Due: 08/02/18

Evaluation of Adherence to Solifenacin Treatment in Overactive Bladder Patients

Phase: N/A Priority: Normal
NCT ID: NCT00985387 Org: User:
Start: 08/31/09 End: 08/31/11 Due: 08/31/12

A Study to Investigate the Effect of ASP1517 After Intermittent Oral Dosing in Dialysis Chronic Kidney Disease Patients With Anemia Compared With Darbepoetin as a Reference Drug

Phase: N/A Priority: Normal
NCT ID: NCT01888445 Org: User:
Start: 03/28/13 End: 09/15/14 Due: 09/15/15

Multiple Oral Administration of ASP7991 to Non-elderly Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01872013 Org: User:
Start: 11/30/12 End: 02/28/13 Due: 02/28/14

Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Pediatric Patients With Mild Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT00667160 Org: User:
Start: 12/31/02 End: 11/30/03 Due: 11/30/04

Study of an Investigational Drug, ASP3026, in Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01401504 Org: User:
Start: 05/31/11 End: 01/31/14 Due: 01/31/15

An Open-label Phase I Study of Orally Available Novel Small-molecule Fibroblast Growth Factor Receptors (FGFR) 1,2,3 and 4 Inhibitor, ASP5878 at Single and Multiple Doses in Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02038673 Org: User:
Start: 11/05/13 End: 07/19/17 Due: 07/19/18

Drug Interaction Study of Isavuconazole and Tacrolimus

Phase: N/A Priority: Normal
NCT ID: NCT01535547 Org: User:
Start: 12/31/11 End: 01/31/12 Due: 01/31/13

A Study to Assess the Safety and Pharmacokinetics of Isavuconazole in Healthy Chinese Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01555918 Org: User:
Start: 08/31/12 End: 11/30/12 Due: 11/30/13

A Study to Compare the Efficacy and Safety of Tacrolimus Capsules in Patient With Myasthenia Gravis

Phase: N/A Priority: Normal
NCT ID: NCT01325571 Org: User:
Start: 03/31/11 End: 05/31/14 Due: 05/31/15

A Study is to Assess Efficacy and Safety of Tacrolimus in Active Rheumatoid Arthritis Patients Who Showed Unsuccessful Response to Existing Disease Modifying Antirheumatic Drugs (DMARDs)

Phase: N/A Priority: Normal
NCT ID: NCT01511003 Org: User:
Start: 12/05/11 End: 05/11/15 Due: 05/11/16

Pharmacokinetics Study in Patients With Impaired Hepatic Function

Phase: N/A Priority: Normal
NCT ID: NCT02586194 Org: User:
Start: 12/28/15 End: 09/27/16 Due: 09/27/17

A Study of YM155 Plus Docetaxel as First-Line Treatment in Subjects With HER2 Negative Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01038804 Org: User:
Start: 12/31/09 End: 06/30/13 Due: 06/30/14

A Study to Assess Safety and Efficacy of ASP1941 in Combination With Nateglinide in Type 2 Diabetic Patients

Phase: N/A Priority: Normal
NCT ID: NCT01316107 Org: User:
Start: 01/15/11 End: 10/19/12 Due: 10/19/13

Study of Ipragliflozin in Patients With Type 2 Diabetes Mellitus Receiving Insulin Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02847091 Org: User:
Start: 07/29/16 End: 11/09/17 Due: 11/09/18

A Study of ASP1941 in Combination With Insulin in Patients With Type 1 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02897219 Org: User:
Start: 08/29/16 End: 03/15/18 Due: 03/15/19

Post-marketing Surveillance of Bixalomer in Patients With Pre-dialysis Chronic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT02805348 Org: User:
Start: 06/01/16 End: 12/31/18 Due: 12/31/19

Development of Visual Function Evaluation Method

Phase: N/A Priority: Normal
NCT ID: NCT03281005 Org: User:
Start: 11/01/17 End: 11/21/19 Due: 11/21/20

A Phase 4 Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Male Subjects With Overactive Bladder (OAB) Symptoms, While Taking the Alpha Blocker for Benign Prostatic Hypertrophy (BPH)

Phase: N/A Priority: Normal
NCT ID: NCT02656173 Org: User:
Start: 01/25/16 End: 07/21/17 Due: 07/21/18